Literature DB >> 12419432

Meta-analysis of rates of erectile function after treatment of localized prostate carcinoma.

John W Robinson1, Sabine Moritz, Tak Fung.   

Abstract

PURPOSE: The results of a 1997 meta-analysis of the rates of erectile function after external beam radiotherapy (EBRT) and radical prostatectomy have been widely used in patient and professional education materials and as a reference against which new findings are compared. With a number of recent publications, it is now possible to update this analysis and compare brachytherapy with or without EBRT with EBRT alone, standard and nerve-sparing radical prostatectomy, and cryotherapy.
METHODS: A comprehensive literature review and subsequent meta-analysis of the rates of erectile dysfunction associated with the treatments of localized prostate carcinoma was conducted. A simple logistic regression analysis was used to combine the data from the 54 articles that met the selection criteria.
RESULTS: The predicted probability of maintaining erectile function after brachytherapy was 0.76, after brachytherapy plus EBRT 0.60, after EBRT 0.55, after nerve-sparing radical prostatectomy 0.34, after standard radical prostatectomy 0.25, and after cryotherapy 0.13. When only studies reporting > or = 2 years follow-up were considered, the only significant change was a decline in the probability for nerve-sparing radical prostatectomy. No brachytherapy studies had a follow-up of > or = 2 years. When the probabilities were adjusted for age, the spread between the RT methods and surgical approaches was greater.
CONCLUSION: The differences in the probability of maintaining erectile function after different treatments of localized prostate cancer are significant.

Entities:  

Mesh:

Year:  2002        PMID: 12419432     DOI: 10.1016/s0360-3016(02)03030-4

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  38 in total

Review 1.  Prostate cancer treatment. The case for radical prostatectomy.

Authors:  Miles A Goldstraw
Journal:  Ann R Coll Surg Engl       Date:  2006-09       Impact factor: 1.891

2.  [Treatment strategies for local advanced prostate cancer].

Authors:  T Kälble
Journal:  Urologe A       Date:  2008-11       Impact factor: 0.639

Review 3.  [Radiotherapy for locally advanced prostate cancer].

Authors:  K Herfarth; F Sterzing
Journal:  Urologe A       Date:  2008-11       Impact factor: 0.639

4.  Secondary effects and biochemical control in patients with early prostate cancer treated with (125)-I seeds.

Authors:  V Morillo; J L Guinot; I Tortajada; J V Ricós; L Arribas; M Maroñas; M Estornell; J Casanova
Journal:  Clin Transl Oncol       Date:  2008-06       Impact factor: 3.405

5.  Five-year potency preservation after iodine-125 prostate brachytherapy.

Authors:  Shuichi Nishimura; Atsunori Yorozu; Toshio Ohashi; Masanori Sakayori; Yasuto Yagi; Toru Nishiyama; Shiro Saito; Yutaka Shiraishi; Kayo Yoshida; Kazuhito Toya; Naoyuki Shigematsu
Journal:  Int J Clin Oncol       Date:  2013-10-31       Impact factor: 3.402

Review 6.  High dose rate prostate brachytherapy: an overview of the rationale, experience and emerging applications in the treatment of prostate cancer.

Authors:  A Challapalli; E Jones; C Harvey; G O Hellawell; S A Mangar
Journal:  Br J Radiol       Date:  2012-11       Impact factor: 3.039

Review 7.  Prostate brachytherapy for localized prostate cancer.

Authors:  Jay P Ciezki
Journal:  Curr Treat Options Oncol       Date:  2005-09

Review 8.  What happened? Sexual consequences of prostate cancer and its treatment.

Authors:  Anne Katz
Journal:  Can Fam Physician       Date:  2005-07       Impact factor: 3.275

9.  Stereotactic body radiotherapy for organ-confined prostate cancer.

Authors:  Alan J Katz; Michael Santoro; Richard Ashley; Ferdinand Diblasio; Matthew Witten
Journal:  BMC Urol       Date:  2010-02-01       Impact factor: 2.264

10.  Stamp test delivers message on erectile dysfunction after high-dose intensity-modulated radiotherapy for prostate cancer.

Authors:  Lanea M M Keller; Mark K Buyyounouski; Dennis Sopka; Karen Ruth; Tracy Klayton; Alan Pollack; Deborah Watkins-Bruner; Richard Greenberg; Robert Price; Eric M Horwitz
Journal:  Urology       Date:  2012-06-29       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.